Please Wait.....
Report
Europe Drug modeling software Market - Industry Trends and Forecast to 2030
Market Report I 2023-06-01 I 276 Pages I Data Bridge Market Research
The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.
Market Segmentation:
Europe Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country (Germany, France , U.K., Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium,Poland, Sweden, Denmark, Finland, Norway, Rest of Europe)- Industry Trends and Forecast to 2030
Overview of Drug Modeling Software Market Dynamics :
Driver
- Rising drug discovery and development activities
Restrain
- Lack of quality data base
Opportunity
- Cloud computing and big data analytics in drug modelling
Market Players:
The key market players operating in the drug modeling software market are listed below:
- Dotmatics
- BC Platforms
- InSilicoTrials Technologies.
- VeriSIM Life., Atomwise Inc.
- Certara, USA.
- GENECODE
- Cresset., and Nanome Inc.
- SIMULATIONS PLUS.
- Dassault Systemes
- Scripps Research
- XtalPi Inc.
- Xybion
- ArgusLab
- Schrodinger, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 57
1.1 OBJECTIVES OF THE STUDY 57
1.2 MARKET DEFINITION 57
1.3 OVERVIEW OF THE EUROPE DRUG MODELING SOFTWARE MARKET 57
1.4 CURRENCY AND PRICING 59
1.5 LIMITATIONS 59
1.6 MARKETS COVERED 59
2 MARKET SEGMENTATION 62
2.1 MARKETS COVERED 62
2.2 GEOGRAPHICAL SCOPE 63
2.3 YEARS CONSIDERED FOR THE STUDY 64
2.4 DBMR TRIPOD DATA VALIDATION MODEL 65
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 68
2.6 MULTIVARIATE MODELING 69
2.7 COMPONENT LIFELINE CURVE 69
2.8 DBMR MARKET POSITION GRID 70
2.9 VENDOR SHARE ANALYSIS 71
2.10 MARKET APPLICATION COVERAGE GRID 72
2.11 SECONDARY SOURCES 73
2.12 ASSUMPTIONS 73
3 EXECUTIVE SUMMARY 74
3.1 PORTER'S FIVE FORCES MODEL 78
3.2 VALUE CHAIN ANALYSIS 79
3.3 REGULATORY STANDARDS 80
3.4 TECHNOLOGICAL TRENDS 81
3.5 BENEFITS OF DRUG MODELING SOFTWARE 82
4 MARKET OVERVIEW 83
4.1 DRIVERS 85
4.1.1 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 85
4.1.2 RISING DEMAND FOR NOVEL THERAPIES 87
4.1.3 PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING 88
4.2 RESTRAINTS 89
4.2.1 LACK OF QUALITY DATA BASE 89
4.2.2 HIGH COST OF MANUFACTURING OF DRUG MODELLING SOFTWARE 89
4.3 OPPORTUNITIES 90
4.3.1 CLOUD COMPUTING AND BIG DATA ANALYTICS IN DRUG MODELLING 90
4.3.2 INCREASING ADOPTION OF MODELLING TOOLS IN DRUG DISCOVERY 91
4.4 CHALLENGES 91
4.4.1 LACK OF PROCEDURE FOR MULTI-DRUG EFFECT ASSESMENT 91
4.4.2 CHALLENGES WITH MODEL INTERPRETATION 92
5 EUROPE DRUG MODELING SOFTWARE MARKET, BY COMPONENTS 93
5.1 OVERVIEW 94
5.1.1 SOFTWARE 97
5.1.1.1 INTEGRATED 98
5.1.1.2 STANDALONE 98
5.1.1.3 LIGAND BASED 98
5.1.1.4 STRUCTURE BASED 98
5.2 SERVICES 98
5.2.1 PROFESSIONAL SERVICES 99
5.2.1.1 CONSULTING AND TRAINING 100
5.2.1.2 INTEGRATION AND IMPLEMENTATION 100
5.2.1.3 SUPPORT AND MAINTENANCE 100
5.2.2 MANAGED SERVICES 100
6 EUROPE DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM 101
6.1 OVERVIEW 102
6.2 WINDOWS 105
6.3 LINUX 105
6.4 MAC OS 106
6.5 OTHERS 107
7 EUROPE DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE 108
7.1 OVERVIEW 109
7.2 CLOUD BASED 112
7.3 HYBRID-BASED 112
7.4 ON-PREMISES 113
8 EUROPE DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE 114
8.1 OVERVIEW 115
8.2 LARGE ENTERPRISE SIZE 118
8.3 SMALL & MEDIUM ENTERPRISE SIZE 118
9 EUROPE DRUG MODELING SOFTWARE MARKET, BY APPLICATION 120
9.1 OVERVIEW 121
9.2 GRAPHICAL MOLECULAR MODELING 124
9.3 GENE SEQUENCE ANALYSIS 124
9.4 PROTEIN MODELING 125
9.5 MODELING CRYSTAL STRUCTURES 126
9.6 CHEMINFORMATICS 127
9.7 HIGH THROUGHPUT VIRTUAL SCREENING 128
9.8 GAS & SOLUTION PHASE REACTION 128
9.9 MEDICAL IMAGING 129
9.10 OTHERS 130
10 EUROPE DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL 131
10.1 OVERVIEW 132
10.2 SUBSCRIPTION BASED 135
10.2.1 ANNUALLY SUBSCRIPTION 136
10.2.2 MONTHLY SUBSCRIPTION 136
10.3 ONE-TIME LICENSE 136
10.3.1 GROUP LICENSE 137
10.3.2 DESKTOP LICENSE 137
10.3.3 OTHERS 137
11 EUROPE DRUG MODELING SOFTWARE MARKET, BY END USER 138
11.1 OVERVIEW 139
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 142
11.2.1 LARGE ENTERPRISE SIZE 143
11.2.2 SMALL & MEDIUM ENTERPRISE SIZE 143
11.3 CONTRACT RESEARCH ORGANIZATIONS 143
11.3.1 LARGE ENTERPRISE SIZE 144
11.3.2 SMALL & MEDIUM ENTERPRISE SIZE 144
11.4 RESEARCH INSTITUTES 144
11.4.1 LARGE ENTERPRISE SIZE 145
11.4.2 SMALL & MEDIUM ENTERPRISE SIZE 145
11.5 REGULATORY AUTHORITIES 145
11.5.1 LARGE ENTERPRISE SIZE 146
11.5.2 SMALL & MEDIUM ENTERPRISE SIZE 147
11.6 OTHERS 147
11.6.1 LARGE ENTERPRISE SIZE 148
11.6.2 SMALL & MEDIUM ENTERPRISE SIZE 148
12 EUROPE DRUG MODELING SOFTWARE MARKET, BY REGION 149
12.1 EUROPE 150
12.1.1 GERMANY 161
12.1.2 FRANCE 166
12.1.3 U.K. 171
12.1.4 ITALY 176
12.1.5 RUSSIA 181
12.1.6 SPAIN 186
12.1.7 TURKEY 191
12.1.8 NETHERLANDS 196
12.1.9 SWITZERLAND 201
12.1.10 BELGIUM 206
12.1.11 POLAND 211
12.1.12 SWEDEN 216
12.1.13 DENMARK 221
12.1.14 FINLAND 226
12.1.15 NORWAY 231
12.1.16 REST OF EUROPE 236
13 EUROPE DRUG MODELING SOFTWARE MARKET: COMPANY LANDSCAPE 237
13.1 COMPANY SHARE ANALYSIS: EUROPE 237
14 SWOT ANALYSIS 238
15 EUROPE DRUG MODELING SOFTWARE MARKET, COMPANY PROFILE 239
15.1 DASSAULT SYSTEMES 239
15.1.1 COMPANY SNAPSHOT 239
15.1.2 REVENUE ANALYSIS 239
15.1.3 COMPANY SHARE ANALYSIS 240
15.1.4 PRODUCT PORTFOLIO 240
15.1.5 RECENT DEVELOPMENT 240
15.2 AMAZON WEB SERVICES, INC. OR ITS AFFILIATES.(A SUBSIDIARY OF AMAZON) 241
15.2.1 COMPANY SNAPSHOT 241
15.2.2 REVENUE ANALYSIS 241
15.2.3 COMPANY SHARE ANALYSIS 242
15.2.4 PRODUCT PORTFOLIO 242
15.2.5 RECENT DEVELOPMENTS 242
15.3 CERTARA, USA. 243
15.3.1 COMPANY SNAPSHOT 243
15.3.2 REVENUE ANALYSIS 243
15.3.3 COMPANY SHARE ANALYSIS 244
15.3.4 PRODUCT PORTFOLIO 244
15.3.5 RECENT DEVELOPMENTS 244
15.4 SCHRODINGER, INC. 245
15.4.1 COMPANY SNAPSHOT 245
15.4.2 REVENUE ANALYSIS 245
15.4.3 COMPANY SHARE ANALYSIS 246
15.4.4 PRODUCT PORTFOLIO 246
15.4.5 RECENT DEVELOPMENT 246
15.5 CRESSET. 247
15.5.1 COMPANY SNAPSHOT 247
15.5.2 COMPANY SHARE ANALYSIS 247
15.5.3 PRODUCT PORTFOLIO 248
15.5.4 RECENT DEVELOPMENTS 248
15.6 ACELLERA LTD 249
15.6.1 COMPANY SNAPSHOT 249
15.6.2 PRODUCT PORTFOLIO 249
15.6.3 RECENT DEVELOPMENTS 249
15.7 ARGUSLAB 250
15.7.1 COMPANY SNAPSHOT 250
15.7.2 PRODUCT PORTFOLIO 250
15.7.3 RECENT DEVELOPMENT 250
15.8 ATOMWISE INC. 251
15.8.1 COMPANY SNAPSHOT 251
15.8.2 PRODUCT PORTFOLIO 251
15.8.3 RECENT DEVELOPMENT 251
15.9 BC PLATFORMS 252
15.9.1 COMPANY SNAPSHOT 252
15.9.2 PRODUCT PORTFOLIO 252
15.9.3 RECENT DEVELOPMENTS 253
15.10 BIOSOLVEIT GMBH 254
15.10.1 COMPANY SNAPSHOT 254
15.10.2 PRODUCT PORTFOLIO 254
15.10.3 RECENT DEVELOPMENT 254
15.11 DOTMATICS 255
15.11.1 COMPANY SNAPSHOT 255
15.11.2 PRODUCT PORTFOLIO 255
15.11.3 RECENT DEVELOPMENTS 256
15.12 GENECODE 257
15.12.1 COMPANY SNAPSHOT 257
15.12.2 PRODUCT PORTFOLIO 257
15.12.3 RECENT DEVELOPMENT 257
15.13 INSILICOTRIALS TECHNOLOGIES. 258
15.13.1 COMPANY SNAPSHOT 258
15.13.2 PRODUCT PORTFOLIO 258
15.13.3 RECENT DEVELOPMENTS 259
15.14 NANOME INC. 260
15.14.1 COMPANY SNAPSHOT 260
15.14.2 PRODUCT PORTFOLIO 260
15.14.3 RECENT DEVELOPMENT 260
15.15 OPTIBRIUM, LTD. 261
15.15.1 COMPANY SNAPSHOT 261
15.15.2 PRODUCT PORTFOLIO 261
15.15.3 RECENT DEVELOPMENT 261
15.16 PHARMACELERA 262
15.16.1 COMPANY SNAPSHOT 262
15.16.2 PRODUCT PORTFOLIO 262
15.16.3 RECENT DEVELOPMENT 262
15.17 SIMULATIONS PLUS. 263
15.17.1 COMPANY SNAPSHOT 263
15.17.2 REVENUE ANALYSIS 264
15.17.3 COMPANY SHARE ANALYSIS 265
15.17.4 PRODUCT PORTFOLIO 265
15.17.5 RECENT DEVELOPMENT 266
15.18 THE SCRIPPS RESEARCH INSTITUTE 267
15.18.1 COMPANY SNAPSHOT 267
15.18.2 PRODUCT PORTFOLIO 267
15.18.3 RECENT DEVELOPMENT 267
15.19 VERISIM LIFE. 268
15.19.1 COMPANY SNAPSHOT 268
15.19.2 PRODUCT PORTFOLIO 268
15.19.3 RECENT DEVELOPMENTS 268
15.20 XTALPI INC. 269
15.20.1 COMPANY SNAPSHOT 269
15.20.2 PRODUCT PORTFOLIO 269
15.20.3 RECENT DEVELOPMENT 269
15.21 XYBION DIGITAL INC. 270
15.21.1 COMPANY SNAPSHOT 270
15.21.2 REVENUE ANALYSIS 270
15.21.3 PRODUCT PORTFOLIO 271
15.21.4 RECENT DEVELOPMENT 271
16 QUESTIONNAIRE 272
17 RELATED REPORTS 276
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security